On-Pump, Beating-Heart Coronary Artery Operations in High-Risk Patients: An Acceptable Trade-off?
|
|
- Jemimah Stokes
- 5 years ago
- Views:
Transcription
1 On-Pump, Beating-Heart Coronary Artery Operations in High-Risk Patients: An Acceptable Trade-off? Louis P. Perrault, MD, PhD, Philippe Menasché, MD, PhD, Jacqueline Peynet, MD, Bouchaib Faris, MD, Alain Bel, MD, Thierry de Chaumaray, MD, Claire Gatecel, MD, Bernard Touchot, MD, Gérard Bloch, MD, and Jean-Marie Moalic, PhD Department of Cardiovascular Surgery and INSERM U-127, Hôpital Lariboisière, Paris, France Background. Current cardioplegic techniques do not consistently avoid myocardial ischemic damage in highrisk patients undergoing coronary artery bypass grafting. Alternatively, revascularization without cardiopulmonary bypass is not always technically feasible. We investigated whether an intermediary approach based on maintenance of a beating heart with cardiopulmonary bypass support but without aortic cross-clamping might be an acceptable trade-off. Methods. Thirty-seven consecutive patients underwent coronary artery bypass grafting (with an average of two grafts per patient) in a pump-supported, non crossclamped beating heart. Inclusion criteria were poor left ventricular function (18 patients; mean ejection fraction, 0.25), evolving myocardial ischemia or infarction (11 patients, 5 of whom were in cardiogenic shock), and advanced age (3 patients; mean age 79.5 years) with comorbidities. Results were assessed primarily on the basis of clinical outcome. In addition, measurements of plasma levels of markers of myocardial damage (troponin I c ) and systemic inflammation (interleukin-6, interleukin-10, elastase) were done in 9 patients before and after bypass. In 6 patients, right atrial biopsy specimens were taken before and after bypass and processed by Northern blotting for the expression of messenger ribonucleic acid coding for the cardioprotective heat-shock protein 70. These biologic data were compared with those from control patients who underwent warm cardioplegic arrest within the same time span. Results. There was one cardiac-related death (2.7%), one Q-wave myocardial infarction, and no strokes. Four other deaths occurred from noncardiac causes, yielding an overall mortality rate of 13.5%. Limitation of myocardial injury was demonstrated by the minimal increase in postoperative troponin I c levels ( g/l versus g/l in controls; p < 0.05) and the finding that heat-shock protein 70 messenger ribonucleic acid levels (expressed as a percentage of an internal standard) were significantly increased after bypass compared with prebypass values (279% 80% versus 97% 21%; p < 0.05). In the control group (cardioplegia), end-arrest values of heat-shock protein 70 messenger ribonucleic acid were not significantly changed from baseline (148% 49% versus 91% 29%), a finding suggesting a defective adaptive response to surgical stress. Conversely, peak levels of inflammatory mediators were not significantly different between the two groups. The eight grafts to the left anterior descending coronary artery that were assessed angiographically, by transthoracic Doppler echocardiography, or both methods were patent with satisfactory anastomoses. Conclusions. In select high-risk patients, on-pump, beating-heart coronary artery bypass grafting may be an acceptable trade-off between conventional cardioplegia and off-pump operations. It is still associated with the potentially detrimental effects of cardiopulmonary bypass but eliminates intraoperative global myocardial ischemia. (Ann Thorac Surg 1997;64: ) 1997 by The Society of Thoracic Surgeons Recently, minimally invasive coronary artery bypass grafting has been the subject of several studies, with emphasis usually put on the switch from conventional median sternotomy to minithoracotomy [1, 2] or even port access [3]. We believe, however, that the invasiveness of coronary artery operations is determined more by Accepted for publication June 3, Address reprint requests to Dr Menasché, Hôpital Lariboisière, 2 rue Ambroise Paré, Paris Cedex, France. myocardial ischemia incurred during the cross-clamping period and the inflammatory response to cardiopulmonary bypass (CPB) than by the site and type of incision. Ideally, these two issues are addressed by off-pump surgery, but this strategy, which is far from new [4], raises the very concerns that led to the development of CPB. An intermediary option is to continue to use CPB but to eliminate the ischemic component of invasiveness by avoiding aortic cross-clamping and keeping the heart beating throughout the operation. Here we report our experience with this technique in a select group of by The Society of Thoracic Surgeons /97/$17.00 Published by Elsevier Science Inc PII S (97)
2 Ann Thorac Surg PERRAULT ET AL 1997;64: BEATING-HEART CORONARY ARTERY OPERATIONS 1369 Table 1. Patient Data a Beating Heart Group (n 37) Variable Subgroup A (EF 0.30) (n 18) Subgroup B (Emergency) (n 11) Subgroup C (Age/Comorbidities) (n 8) Age (y) Sex ratio (male/female) 17/1 7/4 8/0 Unstable angina Preop IABP Cardiogenic shock LV ejection fraction a Data are shown either as the mean the standard error of the mean or as number of patients. EF ejection fraction; IABP intraaortic balloon pump; LV left ventricular. high-risk patients deemed most likely to benefit from a reduction in perioperative myocardial ischemic injury. Material and Methods Thirty-seven patients were consecutively enrolled in this study. They were divided into three subgroups on the basis of the indications for on-pump, beating-heart coronary artery bypass: subgroup A, poor left ventricular function defined as a left ventricular ejection fraction of 0.30 or less; subgroup B, evolving myocardial ischemia or infarction at the time of operation; and subgroup C, advanced age with major comorbidities (Table 1). Eighteen patients, 17 men and 1 woman with a mean age of 64 years (range, 40 to 80 years), had poor left ventricular function (mean ejection fraction, 0.25). Six of them required intraaortic balloon pump support before the operation. Eleven patients underwent urgent or emergent coronary artery bypass grafting for evolving myocardial ischemia refractory to medical therapy, including intravenous administration of nitroglycerin. Five were in cardiogenic shock complicating an acute myocardial infarction. There were 7 men and 4 women with an average of 68 years (range, 41 to 85 years). Eight patients in this subgroup had insertion of an intraaortic balloon pump before the operation. The third subgroup comprised 8 elderly men (mean age, 79.5 years; range, 69 to 83 years) with major renal (4 patients) or neurologic comorbidities (2 patients). Distribution of coronary artery disease and operative data are presented in Table 2. In 31 patients, total CPB was established with a Duraflo II heparin-coated circuit (Baxter Healthcare Corp, Bentley Division, Irvine, CA) between the two individually cannulated venae cavae and the ascending aorta. A membrane oxygenator was used in all operations, and the left ventricle was consistently vented through the right superior pulmonary vein. In the 6 remaining patients (5 from subgroup A, 1 from subgroup B), left heart bypass was instituted between the left atrium and the ascending aorta using a similar heparin-coated tubing and a centrifugal pump (Bio-Medicus, Minneapolis, MN). In all patients, core temperature was allowed to drift, usually to 33 to 34 C, and ventilation was maintained throughout the operation. The target vessel was occluded proximally and distally using a 4-0 polytetrafluoroethylene suture passed twice beneath the artery and mattressed on a small piece of silicone tubing to prevent direct contact between the suture and the anterior coronary artery wall. In 13 patients, a bolus dose of 1 mg/kg of esmolol hydrochloride (Brevibloc; Gensia, Bracknell, UK) was used to slow the heart rate. The efficacy of this drug, however, has been inconsistent, and with increasing experience, the use of drugs intended to cause bradycardia has been discontinued. The first saphenous vein graft was anastomosed distally to the target coronary vessel and then to the aorta with the aid of a side-biting clamp after careful digital palpation of the aorta and with the pump off. When a second venous conduit had to be placed, its proximal end was sutured first to the aorta during the same period of partial occlusion, both to avoid repeated applications of the side-biting clamp and to allow for immediate myocardial revascularization on completion of the corresponding distal anastomosis. The left internal mammary artery left anterior descending coronary artery anastomosis was constructed last when the saphenous vein grafts were already functional. All distal anastomoses were performed with running sutures of 7-0 or 8-0 Prolene (Ethicon, Somerville, NJ). Each patient received Table 2. Summary of Operative Data Variable Beating Heart Group (n 37) Subgroup A Subgroup B Subgroup C No. of diseased vessels No. of grafts Target vessel LAD LCx RC Esmolol a Data are shown as the mean the standard error of the mean or as number of patients. LAD left anterior descending coronary artery; LCx left circumflex artery; RC right coronary artery.
3 1370 PERRAULT ET AL Ann Thorac Surg BEATING-HEART CORONARY ARTERY OPERATIONS 1997;64: an average of two grafts (range, one to three) with the time of coronary occlusion ranging between 10 to 20 minutes. Complete data concerning the extent of revascularization are summarized in Table 2. No coronary arteries were left ungrafted because of technical difficulty. Vessels that were not bypassed either were occluded or were not of critical importance in patients in unstable condition. Results were assessed primarily on clinical outcome, which included mortality, Q-wave infarction, requirement of inotropic agents or an intraaortic balloon pump, occurrence of stroke, and time to extubation. The alveolar-arterial oxygen pressure gradient [P(A-a)O 2 ] was calculated at the time of anesthesia induction and on arrival in the intensive care unit with the following formula: P(A-a)O 2 PAo 2 PaO 2, where PAo 2 PiO 2 PaCO 2 /RQ (PiO 2 is the product of the inspired oxygen fraction and the dry barometric pressure [760 mm Hg 47 mm Hg], PaCO 2 is the partial pressure of arterial carbon dioxide, and RQ is the respiratory quotient [taken at 0.77]), and PaO 2 is the partial pressure of arterial oxygen [5]. Eight grafts to the left anterior descending coronary artery (seven mammary arteries, one vein) were controlled by angiography (six grafts; five in subgroup A, one in subgroup B) or transthoracic Doppler echocardiography (two grafts; one in subgroup B, one in subgroup C) within 1 week postoperatively. Further, in 9 randomly selected patients (5 from subgroup A, 2 from subgroup B, 2 from subgroup C), arterial blood samples were collected preoperatively and 4 hours after completion of CPB. Samples were processed for the determination of troponin I c, interleukin-6, interleukin-10, and elastase using enzyme-linked immunosorbent assays (troponin I c : Dade, Massy, France; interleukins 6 and 10: R & D Systems, Minneapolis, MN; elastase: Merck Diagnostica, Darmstadt, Germany). All postbypass values were corrected for hemodilution. In 6 patients (all from subgroup A), right atrial biopsy specimens were taken before and after bypass and processed by Northern blotting for the expression of messenger ribonucleic acid (mrna) coding for the cardioprotective heat-shock protein (HSP) 70, as previously described [6]. Data on troponin I c, inflammatory mediators, and HSP 70 mrna were compared with those obtained in control patients operated on during the same period with the use of continuous retrograde warm blood cardioplegia and a similar heparin-coated extracorporeal circuit. Results were compared using paired and unpaired Student s t tests, where appropriate. Statistical significance was set at the 0.05 level. Data are expressed as the mean the standard error of the mean. Results There was one cardiac-related death. A 71-year-old woman underwent emergent redo operation for unstable angina complicated by congestive heart failure requiring balloon pump support. Despite an uneventful triple bypass procedure, a low-output state persisted postoperatively and ultimately caused her death 14 days after the operation. There were four other deaths from noncardiac causes. Two patients died of multiorgan failure complicating preoperative cardiogenic shock. In both, myocardial function had recovered in the early postoperative period, and this allowed 1 to be successfully weaned from a left ventricular assist device after 11 days of support. A 75-year-old man with diffuse atherosclerotic disease died on the fourth postoperative day of massive gastric bleeding that caused irreversible hypotension before a laparotomy could be performed. At postmortem examination, the endarterectomized left anterior descending coronary artery and the internal mammary artery graft were patent. A 78-year-old man died suddenly on postoperative day 4 of a pulmonary embolism documented at postmortem examination. Thus, the overall operative mortality rate was 13.5% (5/37), but the cardiac-related mortality rate was only 2.7%.* One patient sustained a nonfatal Q-wave infarction. Postoperative inotropic support for more than 24 hours and an intraaortic balloon pump were required in 8 and 4 patients, respectively. No patient had a stroke. Twentyseven patients were extubated within 18 hours after operation, and the early postoperative alveolar-arterial oxygen pressure gradient (at an inspired oxygen fraction of 1.0) was not significantly different from the prebypass value ( mm Hg and mm Hg, respectively). Clinical outcomes were not different between patients having operation on full versus left heart bypass only. The eight left anterior descending coronary artery bypass grafts assessed postoperatively were patent with normal anastomoses and flows. Postoperative levels of troponin I c were twofold lower in the beating heart group compared with the cardioplegia group ( g/l versus g/l in 11 controls; p 0.05). Additional evidence for the superior myocardial protection afforded by the beating heart technique is based on the finding that in the beating heart group, postbypass values for HSP 70 mrna (expressed as a percentage of an internal standard) were significantly increased after bypass compared with prebypass values (279% 80% versus 97% 21%, p 0.05), whereas in 10 control patients undergoing continuous warm cardioplegia, end-arrest values of HSP 70 mrna were not significantly different from baseline (148% 49% versus 91% 29%). Conversely, there were no significant differences in the postbypass release of interleukin-6, interleukin-10, and elastase between the two groups (Table 3). Comment Despite the major advances in myocardial protection that have occurred over the last decade, postoperative adverse events related to intraoperative ischemia have not been completely eliminated. Even continuous warm * Since the manuscript was submitted, 6 additional patients have undergone an on-pump beating-heart operation with no deaths. This yields a cardiac-related mortality of 2.3% and an overall mortality rate of 11.6% (5/43).
4 Ann Thorac Surg PERRAULT ET AL 1997;64: BEATING-HEART CORONARY ARTERY OPERATIONS 1371 Table 3. Comparison of Effects of Beating Heart Technique and Warm Blood Cardioplegia on Inflammatory Markers a Variable Beating Heart (n 9) Warm Blood Cardioplegia (n 11) Before CPB 4 Hours After CPB Before CPB 4 Hours After CPB Interleukin-6 (ng/l) , Interleukin-10 (ng/l) Elastase ( g/l) a Data are shown as the mean the standard error of the mean. CPB cardiopulmonary bypass. blood cardioplegia, which is expected to keep the heart in an aerobic environment, does not completely prevent some degree of postoperative stunning [7], possibly because the myocardial edema intrinsic to the diastolic state of the arrested heart can cause cardiac dysfunction [8]. Conversely, keeping the heart beating, even with reduced contractility such as under -blockade, is associated with less myocardial edema and better function [8]. The detrimental effects of aortic cross-clamping are probably inconsequential in the vast majority of patients but may precipitate hemodynamic failure in patients with already marginal left ventricular function. Theoretically, the ideal solution to this problem is myocardial revascularization without extracorporeal circulation. However, this approach raises its own concerns, as demonstrated by the sharp contrast between satisfactory clinical outcomes [9 12] and the low rates of long-term graft patency [13]. We acknowledge that, by virtue of the observational design of this study, the present data do not conclusively establish the superiority of the beating heart technique over any other method of myocardial protection; in fact, excellent clinical results have been reported in high-risk patients with the use of different strategies of cardioplegia [14, 15]. Nevertheless, low ejection fraction, evolving myocardial ischemia, and advanced age are all factors for increased morbidity and mortality after coronary artery bypass grafting [16], and this alone provides a sound rationale for the investigation of alternative surgical approaches in high-risk patients. For this reason, onpump, beating-heart bypass might constitute, in select patients, an interesting trade-off, as suggested by the results reported by Sweeney and Frazier [17] with the use of biventricular assist devices during coronary revascularization in a similar patient population. In keeping with these results, the present data show that maintenance of the heart in a beating state throughout the operation causes less damage than aortic crossclamping, even when blood cardioplegia is used in a continuous fashion. This conclusion is based on two specific findings a lower release of troponin I c, a highly cardiac specific marker of tissue damage [18], and a threefold increase in the postoperative myocardial content of mrna coding for HSP 70 compared with the preoperative value. This result reflects the preserved ability of the beating heart to display an appropriate adaptive response to surgical stress, whereas the arrested heart seems to have lost this capacity, as demonstrated by the fact that levels of HSP 70 mrna at the end of cross-clamping were unchanged from baseline in patients undergoing conventional warm cardioplegic arrest. This observation is consistent with that of McGrath and co-workers [19], who failed to document any change in myocardial levels of HSP 72 in patients protected with cardioplegia when undergoing various open heart operations. Several experimental studies have documented a close relationship between increased myocardial levels of HSPs and attenuation of stunning. Plumier and coauthors [20] and Marber and colleagues [21] have shown improved recovery after ischemia in mice overexpressing the gene for HSP. As ischemia seems to prevent the expression of HSPs [22], the present study documents at the molecular level, the effectiveness of the beating heart technique in ensuring adequate prevention against myocardial injury, thereby making this technique a major component of any minimally invasive procedure. In contrast to the measurements of markers of myocardial damage, those more specific for systemic inflammation were not significantly different between the beating heart technique and warm blood cardioplegia. Of the inflammatory mediators released during CPB, elastase, interleukin-6, and interleukin-10 were selected because they have been shown to be sensitive markers of neutrophil activation, proinflammatory cytokine production, and antiinflammatory cytokine production, respectively [23, 24]. From this standpoint, our results may look disappointing because blood levels of these mediators were not reduced in patients whose hearts were kept beating compared with those having cardioplegic arrest. Nevertheless, the ischemic and reperfused myocardium has been shown to be a major source of inflammatory mediators, in particular neutrophil chemotactic factors and cytokines [25, 26]. Thus, it is possible that we failed to capture this myocardium-specific production because of the timing and site of blood samples. Samples were taken 4 hours after bypass, as previous studies from our institution [27, 28] and others [24, 29] have shown that elastase and interleukin-6 levels peak around this time. This may have led us to miss the release of these mediators from the myocardium, a release that has recently been shown to occur early after aortic unclamping [26]. Also, because at this 4-hour point patients could not have placement of coronary sinus catheters, blood samples were collected from peripheral blood, which
5 1372 PERRAULT ET AL Ann Thorac Surg BEATING-HEART CORONARY ARTERY OPERATIONS 1997;64: does not allow distinction between the myocardial component of elastase and cytokine production and that of systemic origin. There is no question that, regardless of their source, inflammatory mediators were still released in response to CPB. However, there is no conclusive evidence that this translated into clinically relevant postoperative adverse events, in particular in regard to pulmonary function and time to extubation, except for patients in preoperative cardiogenic shock in whom superimposed extracorporeal circulation most likely contributed to the worsening of organ dysfunction. Whether the magnitude of the response was mitigated by the use of heparin-coated circuits, as suggested by some studies [30], cannot be determined from our data. Four limitations of this study need to be addressed. First, one could argue that the comparison of various biologic markers between patients undergoing beatingheart operation and those protected by cardioplegia is flawed by the fact that the two patient populations were not case-matched. This is inherent to the study design, which implied the assignment of all patients meeting the inclusion criteria to the beating heart technique. Nevertheless, despite differences in preoperative clinical characteristics, prebypass values for troponin I c, inflammatory markers, and HSP 70 mrna were not significantly different between the two groups, which permits comparison of postbypass patterns. Second, molecular biologic determinations were made from tissue taken from the right atrium, not the left ventricle. This choice was dictated by obvious ethical considerations. It is clear that we cannot eliminate a spatially heterogeneous distribution of HSP expression [31] with, in particular, a weak expression in the area of regional ischemia possibly created by the vessel occlusion at the time of construction of the distal coronary anastomosis. Third, although we cannot rule out that vessel occlusion may have caused some regional ischemia, its true occurrence is questionable in view of the backflow of blood that consistently exited the distal end of the arteriotomy and that reflects the development of extensive collateralization in chronically ischemic hearts. Fourth, we recognize that complete validation of the technique presented here would require that all grafts be angiographically controlled after operation and followed up for a longer time. However, despite motion of the heart, the on-pump and well-decompressed heart allows the construction of distal coronary anastomoses, including posterior vessels, with an ease that should not compromise technical accuracy. This assumption tends to be supported by the satisfactory patency rates observed in those of our patients in whom left anterior descending coronary artery grafts were controlled postoperatively. In conclusion, we do not believe that the on-pump, beating heart technique is a panacea, but it may be a transitional step to off-pump coronary artery bypass grafting. In select high-risk patients who may poorly tolerate cardioplegic arrest and in situations where offpump surgical intervention is not technically feasible, myocardial revascularization on the pump-supported, non cross-clamped heart may be an acceptable alternative. In some cases, this approach can also be used for revascularizing only posterior vessels in patients whose more accessible coronary arteries are grafted concomitantly without extracorporeal circulation. Doctor Perrault is supported by the Clinician-Scientist program of the Medical Research Council of Canada. We acknowledge the help of Madame Roselyne Prioux in the preparation of the manuscript. References 1. Sani G, Benetti F, Mariani MA, Lisi G, Maccherini M, Toscano M. Arterial myocardial revascularization without cardiopulmonary bypass through a small thoracotomy. Eur J Cardio-thorac Surg 1996;10: Calafiore AM, Di Giammarco G, Teodori G, et al. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 1996;61: Stevens JH, Burdon TA, Siegel LC, et al. Port-access coronary artery bypass with cardioplegic arrest: acute and chronic canine studies. Ann Thorac Surg 1996;62: Ankeney JL. To use or not to use the pump oxygenator in coronary bypass operations [Editorial]. Ann Thorac Surg 1975;19: Birdi I, Regragui IA, Izzat MB, et al. Effects of cardiopulmonary bypass temperature on pulmonary gas exchange after coronary artery operations. Ann Thorac Surg 1996;61: Perrault LP, Menasché P, Bel A, et al. Ischemic preconditioning in cardiac surgery. A word of caution. J Thorac Cardiovasc Surg 1996;112: Misare BD, Krukenkamp BD, Lazer ZP, Levitsky SL. Recovery of postischemic contractile function is depressed by antegrade warm continuous blood cardioplegia. J Thorac Cardiovasc Surg 1993;105: Mehlhorn U, Allen SJ, Adams DL, Davis KL, Gogola GR, Warters RD. Cardiac surgical conditions induced by blockade: effect on myocardial fluid balance. Ann Thorac Surg 1996;62: Benetti FJ, Naselli G, Wood M, Geffner L. Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 1991;100: Pfister AJ, Zaki MS, Garcia JM, et al. Coronary artery bypass without cardiopulmonary bypass. Ann Thorac Surg 1992;54: Moshkowitz Y, Lucky A, Mohr R. Coronary artery bypass without cardiopulmonary bypass. Analysis of short-term and mid-term outcome in 220 patients. J Thorac Cardiovasc Surg 1995;110: Buffolo E, de Andrade JCS, Branco JNR, Teles CA, Aguiar LF, Gomes WJ. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996;61: Gundry SR, Razzouk AJ, Bailey LL. Coronary artery bypass with and without the heart-lung machine: a case-matched 6 year follow-up [Abstract]. Circulation 1996;94(Suppl 1): Dietl CA, Berkheimer MD, Woods EL, Gilbert CL, Pharr WF, Benoit CH. Efficacy and cost-effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less. Ann Thorac Surg 1996;62: Chan RKM, Raman J, Lee KJ, et al. Prediction of outcome after revascularization in patients with poor left ventricular function. Ann Thorac Surg 1996;61: Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996;112: Sweeney MS, Frazier OH. Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg 1992;54:
6 Ann Thorac Surg PERRAULT ET AL 1997;64: BEATING-HEART CORONARY ARTERY OPERATIONS Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993;88: McGrath LB, Locke M, Cane M, Chen C, Ianuzzo CD. Heat shock protein (HSP 72) expression in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1995;109: Plumier JCL, Ross BM, Currie RW, et al. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1995;95: Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1995; 95: Plumier JCL, Robertson HA, Currie RW. Differential accumulation of mrna for immediate early genes and heat shock genes in heart after ischaemic injury. J Mol Cell Cardiol 1996;28: Faymonville ME, Pinc J, Duchateau J, et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 1991;102: Steinberg JB, Kapelanski DP, Olson JD, Weiler JM, Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106: Elgebaly SA, Hashmi FS, Houser SL, Allam ME, Doyle K. Cardiac-derived neutrophil chemotactic factors. Detection in coronary sinus effluents of patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 1992;103: Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112: Menasché P, Haydar S, Peynet J, et al. A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994;107: Menasché P, Peynet J, Larivière J, et al. Does normothermia during cardiopulmonary bypass increase neutrophilendothelium interactions? Circulation 1994;90(Suppl 2): Wan S, Marchant A, DeSmet J, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996;111: Weerwind PW, Maessen JG, van Tits LJH, et al. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg 1995;110: Heads RJ, Latchman DS, Yellon DM. Differential stress protein mrna expression during early ischaemic preconditioning in the rabbit heart and its relationship to adenosine receptor function. J Mol Cell Cardiol 1995;27: Important Announcement for Authors We urge authors interested in submitting manuscripts to The Annals to read carefully the revised and updated Information for Authors sheet found in each issue of the journal. There are many important changes to be noted. For instance, we now require an original and three (instead of two) duplicate manuscripts, and four (instead of three) sets of illustrations. Because of the continuing escalation of production costs, greater attention must be given to the length of papers. Therefore guidelines for the suggested length of various articles are given both in the number of pages and the number of words. There are other significant changes as well. Failure to follow the instructions carefully may result in the manuscript being returned for further processing by The Society of Thoracic Surgeons Ann Thorac Surg 1997;64: /97/$17.00 Published by Elsevier Science Inc PII S (97)
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationSaphenous Vein Autograft Replacement
Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion Operative Technique Rene G. Favaloro, M.D. D irect operation on the coronary artery has been performed in 180 patients
More informationOver the past 2 years, there has been rapid adoption
A Survey on Minimally Invasive Coronary Artery Bypass Grafting Hani Shennib, MD, Michael J. Mack, MD, and Allan G. L. Lee, MSc Divisions of Cardiothoracic Surgery, The Montreal General Hospital, McGill
More informationPort-Access Multivessel Coronary Artery Bypass Grafting
Port-Access Multivessel Coronary Artery Bypass Grafting James I. Fann, Mark A. Groh, Mario F. Pompili, Thomas A. Burdon, and Bruce A. Reitz In the 1950s and 1960s, Drs Dernikhov, Kolesov, and others successfully
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions.
Percutaneous Coronary Intervention https://www.youtube.com/watch?v=bssqnhylvma Types of PCI Procedures Balloon Angioplasty Rotational Atherectomy Coronary Stent Balloon Inflation Rotational Atherectomy
More informationMyocardial revascularization without cardiopulmonary
Multiple Arterial Conduits Without Cardiopulmonary Bypass: Early Angiographic Results Antonio M. Calafiore, MD, Giovanni Teodori, MD, Gabriele Di Giammarco, MD, Giuseppe Vitolla, MD, Nicola Maddestra,
More informationPort-Access Coronary Artery Bypass Grafting With the Use of Cardiopulmonary Bypass and Cardioplegic Arrest
Port-Access Coronary Artery Bypass Grafting With the Use of Cardiopulmonary Bypass and Cardioplegic Arrest Hermann Reichenspurner, MD, PhD, Vassilios Gulielmos, MD, Jaqueline Wunderlich, MD, Markus Dangel,
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationExtra Corporeal Life Support for Acute Heart failure
Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical
More informationIN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION
IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION Michel Carrier, MD L. Conrad Pelletier, MD Raymond Martineau, MD Michel Pellerin, MD
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationAlthough current methods of cardiopulmonary bypass
Transmyocardial Laser as an Adjunct to Minimally Invasive CABG for Complete Myocardial Revascularization Naresh Trehan, MD, Yugal Mishra, PhD, Yatin Mehta, MD, and Dhan Raj Jangid, MD Escorts Heart Institute
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationTo ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW
To ECMO Or Not To ECMO Challenges of venous arterial ECMO Dr Emily Granger St Vincent s Hospital Darlinghurst NSW The Start: 1972 St Vincent s Hospital The Turning Point ECMO program restarted in 2004
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationReoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes
Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University
More informationPerfusion During Coronary and Mitral Valve Surgery Utilizing Minimally Invasive Port-Access Technology
Original Article Perfusion During Coronary and Mitral Valve Surgery Utilizing Minimally Invasive Port-Access Technology John M. Toomasian, MS, CCP*; Dorothy L. Williams, RN, CCP#; Stephen B. Colvin, MD#;
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationCounterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece
John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87
More informationRationale for Prophylactic Support During Percutaneous Coronary Intervention
Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories
More informationTechnical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting
J Med Sci 23;23(2):91-96 http://jms.ndmctsgh.edu.tw/23291.pdf Copyright 23 JMS Kuo-Chen Lee, et al. Technical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting Kuo-Chen Lee, Guo-Jieng
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationCoronary artery bypass grafting (CABG) without an
Coronary Artery Bypass Grafting on the Beating Heart Evaluated With Integrated Backscatter Kenichi Imasaka, MD, Shigeki Morita, MD, Ichiro Nagano, MD, Munetaka Masuda, MD, Ryuji Tominaga, MD, and Hisataka
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationCite this article as:
doi: 10.21037/acs.2018.08.06 Cite this article as: Loforte A, Baiocchi M, Gliozzi G, Coppola G, Di Bartolomeo R, Lorusso R. Percutaneous pulmonary artery venting via jugular vein while on peripheral extracorporeal
More informationAlfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE
Alfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE Management in CHD Medical (medikamentosa) Intervensi 1. Percutaneous ( PTCA & stenting ) 2. Surgical ( CABG, CABG & mitral
More informationHemodynamic Monitoring and Circulatory Assist Devices
Hemodynamic Monitoring and Circulatory Assist Devices Speaker: Jana Ogden Learning Unit 2: Hemodynamic Monitoring and Circulatory Assist Devices Hemodynamic monitoring refers to the measurement of pressure,
More informationDemonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationDistal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty
Distal Coronary rtery Dissection Following Percutaneous Transluminal Coronary ngioplasty Douglas. Murphy, M.D., Joseph M. Craver, M.D., and Spencer. King 111, M.D. STRCT The most common cause of acute
More informationRapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible?
Rapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible? Richard A. Ott, MD, Dan E. Gutfinger, MD, PhD, Mark P. Miller, MD, Hossein Alimadadian, MD, and Teresa M. Tanner Division
More informationInteresting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart. O Wenker, L Chaloupka, R Joswiak, D Thakar, C Wood, G Walsh
ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 3 Number 2 Interesting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart O Wenker, L Chaloupka, R
More informationOPCABG for Full Myocardial Revascularisation How we do it
OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationDeclaration of conflict of interest NONE
Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationEvidence of Systemic Cytokine Release in Patients Undergoing Cardiopulmonary Bypass
The Journal of The American Society of Extra-Corporeal Technology Evidence of Systemic Cytokine Release in Patients Undergoing Cardiopulmonary Bypass Jeffrey Halter, MD; Jay Steinberg, DO; Gregory Fink,
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationThe arterial switch operation has been the accepted procedure
The Arterial Switch Procedure: Closed Coronary Artery Transfer Edward L. Bove, MD The arterial switch operation has been the accepted procedure for the repair of transposition of the great arteries (TGA)
More informationOff-Pump Cardiac Surgery is not Dead
Off-Pump Cardiac Surgery is not Dead Gonzalo J. Carrizo, M.D. Fellow Cardiothoracic Surgery Division Cardiothoracic Surgery Department of Surgery University of Colorado Hopeman Lectureship September 10,2007
More informationClinical material and methods. Department of Cardiovascular Surgery, Hôpital Bon-Secours, Metz, France
Surgical Options for Beating-Heart Aortic Valve Replacement in Patients with Patent Coronary Artery Bypass Daniel Grandmougin, Maria-Christina Delolme, David Derouck, Nabil Yammine, Christophe Minetti,
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationThe first report of the Society of Thoracic Surgeons
REPORT The Society of Thoracic Surgeons National Congenital Heart Surgery Database Report: Analysis of the First Harvest (1994 1997) Constantine Mavroudis, MD, Melanie Gevitz, BA, W. Steves Ring, MD, Charles
More informationLactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery
Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,
More informationMIDCAB Approach for Single Vessel Coronary Artery Bypass Graft
MIDCAB Approach for Single Vessel Coronary Artery Bypass Graft V.A. Subramanian Interest in minimally invasive direct coronary artery bypass (MIDCAB) grafting on the beating heart is growing. The premise
More informationChoice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke
The Journal of The American Society of Extra-Corporeal Technology Choice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke Yasuyuki Shimada, MD, PhD;* Hitoshi Yaku,
More informationJournal of the American College of Cardiology Vol. 33, No. 6, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00061-3 for Prediction
More informationOn-Pump Beating-Heart Coronary Artery Bypass: A Propensity Matched Analysis
On-Pump Beating-Heart Coronary Artery Bypass: A Propensity Matched Analysis Shinichi Mizutani, MD, Akio Matsuura, MD, Ken Miyahara, MD, Tadahito Eda, MD, Akemi Kawamura, MD, Teruaki Yoshioka, MD, and Katsuhiko
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Cardiogenic Shock Mechanical Support Eulàlia Roig FESC Heart Failure and HT Unit Hospital Sant Pau - UAB Barcelona. Spain No conflics of interest Mechanical Circulatory
More informationManagement during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography
Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper
More informationBeating-heart surgery avoids cardiopulmonary bypass
Intraoperative Ischemia and Long-Term Events After Minimally Invasive Coronary Surgery Marco Zimarino, MD, Sabina Gallina, MD, Maria Di Fulvio, MD, Michele Di Mauro, MD, Gabriele Di Giammarco, MD, Raffaele
More informationCoronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy
Coronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy Tom R. Karl, MS, MD he most commonly reported coronary artery malformation leading to sudden death in children and young
More informationMinimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques
Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques Konstadinos A Plestis, MD System Chief of Cardiothoracic and Vascular
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationMinimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases
Original paper Videosurgery Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases Lufeng Zhang, Zhongqi Cui, Zhiming Song, Hang Yang,
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2017 Section: Other/Miscellaneous
More informationMinimally invasive coronary artery bypass grafting
Intraoperative Angiography to Assess Graft Patency After Minimally Invasive Coronary Bypass James A. Goldstein, MD, Robert D. Safian, MD, Darius Aliabadi, MD, William W. O Neill, MD, Francis L. Shannon,
More informationThe use of Intra Aortic Baloon Pump in Patients undergoing Coronary Artery Bypass Grafting at the Aga Khan University Hospital, Karachi
The use of Intra Aortic Baloon Pump in Patients undergoing Coronary Artery Bypass Grafting at the Aga Khan University Hospital, Karachi Aamir M. Jafarey,Muneer Amanullah,Sajid A. Khan,Sulaiman B. Hasan
More informationPheochromocytoma Crisis Presenting as Fulminant Cardiopulmonary Failure: A Case Report
170 Pheochromocytoma Crisis Presenting as Fulminant Cardiopulmonary Failure: A Case Report Chun-Wen Chiu 1, Cheng-Hsiung Chen 2 Fulminant cardiopulmonary failure in a patient with pheochromocytoma is a
More informationCABG Surgery following STEMI
CABG Surgery following STEMI Susana Harrington, MS,APRN-NP Cardio-Thoracic Surgery Nebraska Methodist Hospital February 15, 2018 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationPostoperative stroke after off-pump versus on-pump coronary artery bypass surgery
Postoperative stroke after off-pump versus on-pump coronary artery bypass surgery Fausto Biancari, MD, PhD, Martti Mosorin, MD, Elsi Rasinaho, MS, Jarmo Lahtinen, MD, Jouni Heikkinen, MD, Eija Niemelä,
More informationThe radial procedure was developed as an outgrowth
The Radial Procedure for Atrial Fibrillation Takashi Nitta, MD The radial procedure was developed as an outgrowth of an alternative to the maze procedure. The atrial incisions are designed to radiate from
More informationTracheal stenosis in infants and children is typically characterized
Slide Tracheoplasty for Congenital Tracheal Stenosis Peter B. Manning, MD Tracheal stenosis in infants and children is typically characterized by the presence of complete cartilaginous tracheal rings and
More informationThe Case for Multivessel Revascularization in Shock
The Case for Multivessel Revascularization in Shock Emmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute 9.37 9.49 am Disclosures Consulting/speaker honoraria: Abbott Vascular, American Heart Association
More informationMinimal access aortic valve surgery has become one of
Minimal Access Aortic Valve Surgery Through an Upper Hemisternotomy Approach Prem S. Shekar, MD Minimal access aortic valve surgery has become one of the accepted forms of surgical therapy for patients
More informationCardiovascular Practice Quiz
Cardiovascular Practice Quiz 1. When caring for a patient following a cardiac catheterization with coronary angiography, which of the following findings would be of most concern to the nurse? a. Swelling
More informationEarly Angiographic Results of Multivessel Off-Pump Coronary Artery Bypass Grafting
Original Article Early Angiographic Results of Multivessel Off-Pump Coronary Artery Bypass Grafting Mimiko Tabata, MD, Hiroshi Niinami, MD, PhD, Yuji Suda, MD, Akihito Sasaki, MD, Masato Yamamoto, MD,
More informationHeart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United
Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually
More informationand Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.
Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular
More informationComplete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report
J Cardiol 2004 Nov; 44 5 : 201 205 Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report Takatoshi Hiroshi Akira Takahiro Masayasu
More informationShould We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease?
1 Should We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease? 1 Nasr Hegazy, Khaled Fawzy, 2 Mostafa El-Hamamsy, 3 Abdelsalam Elhenawy
More informationThe most important advantage of CABG over PTCA is its
Coronary Artery Bypass With Only In Situ Bilateral Internal Thoracic Arteries and Right Gastroepiploic Artery Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Masahiro Endo, MD; Hitoshi Koyanagi, MD; Hiroshi
More informationUnderstanding the Cardiopulmonary Bypass Machine and Its Tubing
Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of
More informationAtrial Fibrillation Predicts Worse Long Time Prognosis after CABG A 6-Year Survival Analysis
Open Journal of Thoracic Surgery, 2012, 2, 18-22 http://dx.doi.org/10.4236/ojts.2012.22006 Published Online June 2012 (http://www.scirp.org/journal/ojts) Atrial Fibrillation Predicts Worse Long Time Prognosis
More informationSurgical Thrombectomy for PE: Is it Making a Comeback
Surgical Thrombectomy for PE: Is it Making a Comeback Prashanth Vallabhajosyula, MD MS The University of Pennsylvania Health System Philadelphia, PA Case - 84 year old female presents with submassive right
More informationShould We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary Disease?
Australian Journal of Basic and Applied Sciences, 3(1): 49-54, 2009 ISSN 1991-8178 Should We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary
More informationCPT Code Details
CPT Code 93572 Details Code Descriptor Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationLess-invasive coronary artery bypass grafting: different techniques and approaches
European Journal of Cardio-thoracic Surgery 14 (Suppl. 1) (1998) S13 S19 Less-invasive coronary artery bypass grafting: different techniques and approaches A. Diegeler*, V. Falk, K. Krähling, M. Matin,
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationFurther Evaluation. Technique of Coronary Artery Bypass. of the Circular Sequential Vein Graft
Further Evaluation of the Circular Sequential Vein Graft Technique of Coronary Artery Bypass Joseph C. Cleveland, M.D., Ira M. Lebenson, M.D., Robert J. Twohey, M.D., Joseph G. Ellis, M.D., Daniel B. Nelson,
More informationThe strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?
Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?* Nirupama G. Talwalkar, MD, FCCP; Gerald M. Lawrie, MD, FCCP; Nan Earle, BS; and Michael E. DeBakey, MD, FCCP Background:
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationLeft Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients
Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Armand A. Lefemine, M.D., Rajagopalan Govindarajan, M.D., K. Ramaswamy, M.D., Harrison
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationI internal mammary artery (IMA) is widely accepted as
Routine Use of the Left Internal Mammary Artery Graft in the Elderly Timothy J. Gardner, MD, Peter S. Greene, MD, Mary F. Rykiel, RN, William A. Baumgartner, MD, Duke E. Cameron, MD, Alfred S. Casale,
More informationPredictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years
Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years Khaled D. Algarni, MD, MHS, Manjula Maganti, MS, and Terrence M. Yau, MD, MS Division of Cardiovascular
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/01/2014 Section: Other/Miscellaneous
More informationAcute type A aortic dissection (Type I, proximal, ascending)
Acute Type A Aortic Dissection R. Morton Bolman, III, MD Acute type A aortic dissection (Type I, proximal, ascending) is a true surgical emergency. It is estimated that patients suffering this calamity
More informationConflict of Interest Slide
Comparison of six- month clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation (EECP) for coronary artery disease in the United States and Europe Ozlem
More informationVIDEO-ASSISTED MINIMALLY INVASIVE CORONARY OPERATIONS WITHOUT CARDIOPULMONARY BYPASS: A MULTICENTER STUDY
VIDEO-ASSISTED MINIMALLY INVASIVE CORONARY OPERATIONS WITHOUT CARDIOPULMONARY BYPASS: A MULTICENTER STUDY Federico Benetti, MD a Massimo A. Mariani, MD u Guido Sani, MD b Piet W. Boonstra, MD ~ Jan G.
More informationInnovative ECMO Configurations in Adults
Innovative ECMO Configurations in Adults Practice at a Single Center with Platinum Level ELSO Award for Excellence in Life Support Monika Tukacs, BSN, RN, CCRN Columbia University Irving Medical Center,
More information